ONYX — Onyx Biotec Balance Sheet
0.000.00%
- IN₹972.79m
- IN₹1.01bn
- IN₹619.51m
- 57
- 39
- 19
- 29
Annual balance sheet for Onyx Biotec, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PRESS |
Standards: | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Cash and Short Term Investments | 0.136 | 0.074 | 14.7 | 86.1 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 110 | 53.2 | 156 | 204 |
Total Inventory | ||||
Total Other Current Assets | ||||
Total Current Assets | 144 | 146 | 296 | 492 |
Net Property, Plant And Equipment | 213 | 425 | 435 | 409 |
Other Long Term Assets | ||||
Total Assets | 368 | 587 | 741 | 912 |
Accounts Payable | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 100 | 202 | 226 | 257 |
Long Term Debt | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Deferred Income Tax | ||||
Total Other Liabilities | ||||
Total Liabilities | 205 | 405 | 493 | 356 |
Common Stock | ||||
Retained Earnings (Accumulated Deficit) | ||||
Total Equity | 164 | 182 | 249 | 556 |
Total Liabilities & Shareholders' Equity | 368 | 587 | 741 | 912 |
Total Common Shares Outstanding |